Until July 2023, Marie led Ready2Respond, a unique global coalition of partners committed to augmenting low- and middle-income countries’ vaccine readiness to respond to respiratory pandemics. Marie currently serves on the Strategic Advisory Group of the Partnership for Influenza Vaccine Introduction (PIVI), a program from the Task Force for Global Health and the US Centers for Diseases Control and Prevention. She also serves as Chairman of the Board of Directors of PharmaJet®, a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals delivery.
Marie has 30 years of experience in the pharmaceutical industry including 25 years in the vaccine sector where she held successive global commercial leadership positions at Sanofi Pasteur, GlaxoSmithKline Biologicals and CSL Seqirus. Marie received her doctorate in Pharmacy, and her master’s degree in Regulatory Affairs, from Paris University in France. She is a graduate from INSEAD Business School.